WebDisclosure WebDisclosure
Basculer en Français
9479 Companies
185510 Keywords
117899 Articles
99364 Press releases
Headlines Articles Press releases Moderna, Inc. Remove
  1. Home
  2. Companies
  3. Moderna, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/30/2023 at 13:15, 2 years 10 months ago

    Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/17/2023 at 22:05, 2 years 10 months ago

    Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/09/2023 at 13:00, 2 years 10 months ago

    Moderna Announces Advances Across mRNA Pipeline and Provides Business Update

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/05/2023 at 22:05, 2 years 10 months ago

    Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

    Logo of Moderna, Inc.
Previous page
1 ... 33 34
Accesswire
  • Published on 12/05/2025 at 17:15, 47 minutes ago

    TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference

  • Published on 12/05/2025 at 17:00, 1 hour 2 minutes ago

    Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once

  • Published on 12/05/2025 at 16:00, 2 hours 2 minutes ago

    SMX Didn't Change Its Story; The World Finally Connected the Dots

  • Published on 12/05/2025 at 15:45, 2 hours 17 minutes ago

    Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme

  • Published on 12/05/2025 at 15:45, 2 hours 17 minutes ago

    Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 17:51, 10 minutes ago

    Issue of Equity

  • Published on 12/05/2025 at 17:46, 15 minutes ago

    Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

  • Published on 12/05/2025 at 17:00, 1 hour 1 minute ago

    EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance

  • Published on 12/05/2025 at 16:25, 1 hour 36 minutes ago

    4YFN26 Awards: Meet the Top 20 startups building the future

  • Published on 12/05/2025 at 16:10, 1 hour 52 minutes ago

    Reorganization of the Eckert & Ziegler Executive Board

View all EQS
Les Echos
  • Published on 12/05/2025 at 17:18, 44 minutes ago

    La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

  • Published on 12/05/2025 at 17:18, 44 minutes ago

    The video of the 2024-2025 results presentation meeting on December 5, 2025, is available

  • Published on 12/05/2025 at 15:10, 2 hours 51 minutes ago

    Mersen: Number of shares and voting rights as of November 30, 2025

  • Published on 12/05/2025 at 15:10, 2 hours 51 minutes ago

    Mersen : nombre d'actions et de droits de vote au 30 novembre 2025

  • Published on 12/05/2025 at 13:58, 4 hours 3 minutes ago

    RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy